NEUMORA THERAPEUTICS, INC. (NMRA) Free cash flow 2023–2024
NEUMORA THERAPEUTICS, INC. (NMRA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$183.1MFY2024 · since FY2023: -$163.8M → -$183.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$183.1M | -11.8% |
| FY2023 | -$163.8M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice